1. Home
  2. VTOL vs INBX Comparison

VTOL vs INBX Comparison

Compare VTOL & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bristow Group Inc.

VTOL

Bristow Group Inc.

HOLD

Current Price

$46.00

Market Cap

1.2B

ML Signal

HOLD

Logo Inhibrx Inc.

INBX

Inhibrx Inc.

HOLD

Current Price

$58.33

Market Cap

999.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTOL
INBX
Founded
1948
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
999.7M
IPO Year
2011
2024

Fundamental Metrics

Financial Performance
Metric
VTOL
INBX
Price
$46.00
$58.33
Analyst Decision
Strong Buy
Hold
Analyst Count
3
2
Target Price
$58.00
N/A
AVG Volume (30 Days)
173.9K
143.2K
Earning Date
05-05-2026
03-19-2026
Dividend Yield
1.08%
N/A
EPS Growth
34.58
N/A
EPS
4.32
N/A
Revenue
$1,490,512,000.00
$1,300,000.00
Revenue This Year
$11.64
N/A
Revenue Next Year
$5.59
N/A
P/E Ratio
$10.71
N/A
Revenue Growth
5.30
550.00
52 Week Low
$25.11
$10.81
52 Week High
$49.55
$94.57

Technical Indicators

Market Signals
Indicator
VTOL
INBX
Relative Strength Index (RSI) 57.31 33.28
Support Level $42.83 $28.54
Resistance Level $46.36 $85.97
Average True Range (ATR) 1.21 4.27
MACD 0.17 -0.55
Stochastic Oscillator 88.03 8.45

Price Performance

Historical Comparison
VTOL
INBX

About VTOL Bristow Group Inc.

Bristow Group Inc is the provider of vertical flight solutions. The group provides aviation services to a broad base of offshore energy companies and government entities. Its business comprises three reportable segments: Offshore Energy Services, Government Services, and Other Services. Its customers in Australia, Brazil, Canada, Chile, the Dutch Caribbean, the Falkland Islands, India, Ireland, the Kingdom of Saudi Arabia, Mexico, the Netherlands, Nigeria, Norway, Spain, Suriname, Trinidad, the UK, and the U.S. offshore energy customers use services to transport personnel to, from and between offshore energy installations.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: